Iatrogenic keratectasia after laser in situ keratomileusis (LASIK) represents a serious complication of refractive laser surgery. We describe a woman who developed bilateral iatrogenic keratectasia during her first pregnancy 26 months after LASIK. Corneal collagen crosslinking (CCL) with riboflavin and ultraviolet-A was performed in March 2005 (right eye) and April 2005 (left eye). This treatment stopped the progression and even caused the keratometric steepness to regress over a postoperative follow-up of 22 months, as demonstrated by preoperative and postoperative corneal topographies and maximum K-readings. During the patient's second pregnancy, the keratectasia exacerbated. To our knowledge, this is the first case showing exacerbation of keratectasia despite CCL and, as the exacerbation occurred only during pregnancy, suggesting that hormonal changes might affect corneal biomechanical stability. Laser in situ keratomileusis (LASIK) of the cornea for the correction of myopia is the most frequently performed procedure in ophthalmology. Unfortunately, under certain circumstances, the cornea does not remain biomechanically stable postoperatively and shows signs of iatrogenic keratectasia.
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Laser in situ keratomileusis (LASIK) of the cornea for the correction of myopia is the most frequently performed procedure in ophthalmology. Unfortunately, under certain circumstances, the cornea does not remain biomechanically stable postoperatively and shows signs of iatrogenic keratectasia. 1, 2 Similar to those in keratoconus, the signs include progressive corneal thinning and bulging, an increase in astigmatism, severe corneal scarring, and, ultimately, loss of vision. 3 Randleman et al. 3, 4 recently summarized the risk factors for the induction of this potentially devastating complication: abnormal preoperative topographies, age, high corrections, and thin residual stroma. A subgroup of patients showed no preoperative reason for the development of keratectasia. Thus, unknown factors might be involved in the pathogenesis of this complication.
CASE REPORT
A 33-year-old woman had bilateral LASIK in Mexico in 2000 for myopia of À5.5 À0.5 Â 0 in the right eye and À5.25 À0.75 Â 165 in the left eye. Preoperatively, the best spectaclecorrected visual acuity (BSCVA) was 20/20 in both eyes. According to the surgeon's notes, the preoperative examinations showed no signs of preexisting corneal abnormalities. Laser in situ keratomileusis was performed using a Visx Star S2 excimer laser system at a repetition rate of 10 Hz. The total ablation depth was 68 mm in the right eye and 62 mm in the left eye. Surgery was uneventful in both eyes. However, there is no information available on the flap creation process or on estimated flap thickness and preoperative corneal thickness. After LASIK, the uncorrected visual acuity was 20/20 bilaterally with normal topographies. Ultrasound corneal pachymetry (DGH-5100e, DGH Technology, Inc.) showed a central corneal thickness of 410 mm in the right cornea and 400 mm in the left cornea. Corneal parameters remained stable in the examinations over the following 2 years.
In January 2003, the patient began her first pregnancy. In the seventh gestational month (July 2003), she noted a significant decrease in visual acuity in the right eye, coupled with glare and halos under mesopic conditions. She did not consult an ophthalmologist at that time. In January 2007, the patient began her second pregnancy and in the sixth gestational month (June 2007), she noted a sudden deterioration of vision in the right eye. Corneal topographies showed a progression of keratectasia in the right eye until the end of the second pregnancy. Maximum K-readings reached levels similar to those before CCL (Figure 1, C) . In the left eye, the BSCVA was unchanged, and the topographies were stable.
The patient had never smoked and had no history of allergies or extensive eye rubbing. Her body mass index was between 22.2 and 25.5.
DISCUSSION
Induced keratectasia after LASIK and after photorefractive keratectomy has been widely reported in recent years. Randleman et al. 4 have shown that the most significant risk factor for the development of iatrogenic keratectasia is preoperatively undetected abnormal topographies. Other reported cases of induced keratectasia show no preoperative signs of corneal abnormalities. Furthermore, the postoperative time to occurrence of the first signs of keratectasia varies; in some cases, keratectasia occurred up to 36 months after LASIK. 5 Our case shows late onset of keratectasia and is highly unusual because of the temporal accord with the patient's pregnancies.
There is growing evidence that changes in estrogen levels may play a role in LASIK-induced keratectasia: Estrogen receptors have been identified in the cornea, 6 and exposure to estrogen reduced the biomechanical stability of the cornea in an experimental study. 7 These data suggest that changes in estrogen levels may reduce the biomechanical stability of the cornea, which leads to the onset of iatrogenic keratectasia after LASIK. However, Randleman et al. 4 showed a statistically significantly higher risk for men to develop iatrogenic keratectasia.
Until recently, the only therapeutic option for LASIK-induced keratectasia was keratoplasty. Recently, several groups have reported that CCL with riboflavin and ultraviolet-A can stop and even partially reverse progressive LASIK-induced keratectasia. 8, 9 In our case, CCL stabilized the ectasia and led to a partial regression of maximum K-readings over a period of 2 years. However, during the patient's second pregnancy, the keratectasia exacerbated. One might speculate that this exacerbation was due to a ''poor'' or partial crosslinking effect. The actual amount of the crosslinked stroma cannot be evaluated because no tool provides direct measurement of the CCL effect. However, for several years following the first CCL treatment, the patient's topographies showed stabilization of the keratectasia. A poor crosslinking effect is therefore highly unlikely.
It is unclear why the left eye showed no progression during the second pregnancy. A possible explanation is that the residual stromal bed thickness was slightly greater than in the right eye, which developed keratectasia. In such borderline cases, minimal biomechanical differences, along with pregnancy-induced changes in estrogen levels, might determine whether a cornea develops keratectasia.
In conclusion, changes in the estrogen level during pregnancy might represent a previously unrecognized risk factor for the induction of keratectasia after LASIK surgery. To our knowledge, this is the first case to demonstrate that CCL may not be able to stabilize iatrogenic keratectasia in borderline cases.
